| |
|
| |
 |
| |
|
| |
|
North America
|
|
The seventh edition of Kline's syndicated analysis of the profitability and cost structures of ten leading OTC drug companies in the United States. Company profiles included in this report features overviews of each company's OTC business unit; an...
|
| |
|
North America
|
|
This study examines the issues and opportunities for OTC companies that are promoting their brands in managed care settings. It provides objective insights on complex issues surrounding coverage/promotion of OTCs among managed care organizations...
|
| |
|
North America
|
|
The first study in a series that focuses on retailer perceptions of the leading marketers in the food store, drug store, and mass merchandiser channels. The study provides concise market profiles for five OTC product classes and the top ten OTC drug...
|
| |
|
North America
|
|
Designed as a planning tool, this study is a compilation and assessment of key issues facing individuals who are involved in making decisions regarding the utilization of over-the-counter products in managed care settings. By analyzing specific case...
|
| |
| |
|
| |
|
| |
|
North America
|
|
An in-depth analysis of the prescription cholesterol-lowering drug market and the potential for Rx-to-OTC switches in this class in the United States. The study includes a comprehensive examination of currently available OTCs and consumer products...
|
| |
|
North America, Latin America, East Europe, West Europe, Middle East
|
|
The fifth report in Kline's Rx-to-OTC-switch series provides forecasts of switch-candidate brands and 14 therapeutic classes in nine major markets in Europe, Asia-Pacific, and North America from 2004 to 2009. The study offers realistic, up-to-date...
|
| |
|
North America
|
|
This report provides comprehensive analyses of 12 therapeutic classes and 36 different drugs to predict their likelihood for Rx-to-OTC switch in the United States over a five-year period (2002 to 2006). The study examines potential switches...
|
| |
|
North America
|
|
This study includes 12 comprehensive case studies of the most significant drugs switched from prescription to nonprescription status in the United States since 1984. It provides an overview of the brands and the markets into which the switches...
|
| |
| |
|
| |
|
| |
|
North America
|
|
This study helps current and potential marketers of functional foods better understand the competitive organizational models that are emerging, identify potential partners/acquisitions, or benchmark their efforts against those of the competition...
|
| |
|
| |
